However, the exogenous administration of GLP-1RAs can mitigate sympathetic excitability by suppressing the peripheral chemoreflex originating from the carotid body
They are not designed to optimize individual outcomes
According to the researchers findings, patients in the GLP-1 group had about a 2.56 times higher chance of developing NAION a year later compared to those in the DPP-4 group
Bonus Tip: Some patients use numbing cream or an ice cube for a few seconds before the shot to reduce discomfort
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
Like most supplements, these products arent FDA-regulated , so they dont go through the same testing for safety, quality, or results as prescription medications meaning theres no real proof they work or that they even contain the ingredients they claim to